Utah Medical Products, Inc.
UTMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | $3,048 | $3,041 | $2,902 |
| Dep. & Amort. | – | $758 | $721 | $0 |
| Deferred Tax | – | -$151 | -$209 | $58 |
| Stock-Based Comp. | – | $86 | $82 | $72 |
| Change in WC | – | -$870 | $838 | -$828 |
| Other Non-Cash | – | $2 | -$9 | $733 |
| Operating Cash Flow | – | $2,873 | $4,464 | $2,937 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$51 | -$184 | -$9 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | -$51 | -$184 | -$9 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $0 | $0 |
| Stock Repurch. | – | -$3,487 | -$3,221 | -$6,709 |
| Dividends Paid | – | -$1,001 | -$1,017 | -$1,038 |
| Other Fin. Act. | – | $0 | $0 | $0 |
| Financing Cash Flow | – | -$4,488 | -$4,238 | -$7,747 |
| Forex Effect | – | $520 | $307 | -$657 |
| Net Chg. in Cash | – | -$1,146 | $349 | -$5,476 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $83,325 | $82,976 | $88,452 |
| End Cash | – | $82,179 | $83,325 | $82,976 |
| Free Cash Flow | – | $2,822 | $4,280 | $2,928 |